Literature DB >> 17568475

Effects of alpha2-adrenoceptor agonists on tetrodotoxin-resistant Na+ channels in rat dorsal root ganglion neurons.

A Oda1, H Iida, S Tanahashi, Y Osawa, S Yamaguchi, S Dohi.   

Abstract

BACKGROUND AND
OBJECTIVE: When intrathecally or epidurally administered, alpha2-adrenoceptor agonists produce potent antinociception by affecting the activity of primary afferent fibres and spinal cord neurons. Recent reports have indicated that in dorsal root ganglion neurons, tetrodotoxin-resistant Na+ channels play important roles in the conduction of nociceptive sensation. We therefore investigated the effects of alpha2-adrenoceptor agonists on tetrodotoxin-resistant Na+ currents.
METHODS: Using the whole-cell patch-clamp technique, we recorded tetrodotoxin-resistant Na+ currents from rat dorsal root ganglion neurons.
RESULTS: Both clonidine and dexmedetomidine reduced the peak amplitude of the tetrodotoxin-resistant Na+ current concentration- and use-dependently. The concentration required for a half-maximal effect was significantly lower for dexmedetomidine (58.0 +/- 10.2 micromol) than for clonidine (257.2 +/- 30.9 micromol) at holding potential -70 mV. The current inhibitions induced by these agonists were not prevented by 1 micromol yohimbine, an alpha2-adrenoceptor antagonist. Both clonidine and dexmedetomidine shifted the inactivation curve for the tetrodotoxin-resistant Na+ current in the hyperpolarizing direction. The combinations clonidine with lidocaine and dexmedetomidine with lidocaine produced an additive blockade-type interaction on the tetrodotoxin-resistant Na+ current.
CONCLUSIONS: The results suggest that a direct inhibition of tetrodotoxin-resistant Na+ channels may contribute to the antinociceptive effects of clonidine and dexmedetomidine when used as additives to regional anaesthesia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17568475     DOI: 10.1017/S0265021507000543

Source DB:  PubMed          Journal:  Eur J Anaesthesiol        ISSN: 0265-0215            Impact factor:   4.330


  22 in total

1.  Neurotoxicity of adjuvants used in perineural anesthesia and analgesia in comparison with ropivacaine.

Authors:  Brian A Williams; Karen A Hough; Becky Y K Tsui; James W Ibinson; Michael S Gold; G F Gebhart
Journal:  Reg Anesth Pain Med       Date:  2011 May-Jun       Impact factor: 6.288

2.  High concentrations of dexmedetomidine inhibit compound action potentials in frog sciatic nerves without alpha(2) adrenoceptor activation.

Authors:  Toshifumi Kosugi; Kotaro Mizuta; Tsugumi Fujita; Mikio Nakashima; Eiichi Kumamoto
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

Review 3.  [Background and current use of adjuvants for regional anesthesia : From research to evidence-based patient treatment].

Authors:  M Schäfer; S A Mousa; M Shaqura; S Tafelski
Journal:  Anaesthesist       Date:  2019-01       Impact factor: 1.041

4.  Dexmedetomidine Increases the Latency of Thermal Antinociception in Rats.

Authors:  Yukako Tsutsui; Katsuhisa Sunada
Journal:  Anesth Prog       Date:  2017

5.  A Combination of Dexmedetomidine and Lidocaine Is a Cardiovascularly Safe Dental Local Anesthetic for Hypertensive Rats Treated With a Nonselective β-Adrenergic Antagonist.

Authors:  Yukako Tsutsui; Katsuhisa Sunada
Journal:  Anesth Prog       Date:  2017

6.  Presynaptic inhibition of transient receptor potential vanilloid type 1 (TRPV1) receptors by noradrenaline in nociceptive neurons.

Authors:  Saikat Chakraborty; Vincent Elvezio; Martin Kaczocha; Mario Rebecchi; Michelino Puopolo
Journal:  J Physiol       Date:  2017-02-22       Impact factor: 5.182

7.  Dexmedetomidine and clonidine inhibit the function of Na(v)1.7 independent of α(2)-adrenoceptor in adrenal chromaffin cells.

Authors:  Toyoaki Maruta; Takayuki Nemoto; Shinya Satoh; Tasuku Kanai; Toshihiko Yanagita; Akihiko Wada; Isao Tsuneyoshi
Journal:  J Anesth       Date:  2011-05-24       Impact factor: 2.078

8.  Preventive and therapeutic effects of a beta adrenoreceptor agonist, dobutamine, in carrageenan-induced inflammatory nociception in rats.

Authors:  Tufan Mert; Berin Tugtag; Metin Kilinc; Elif Sahin; Hafize Oksuz; Yasemin Gunes
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

9.  Perineural administration of dexmedetomidine in combination with bupivacaine enhances sensory and motor blockade in sciatic nerve block without inducing neurotoxicity in rat.

Authors:  Chad M Brummett; Mary A Norat; John M Palmisano; Ralph Lydic
Journal:  Anesthesiology       Date:  2008-09       Impact factor: 7.892

10.  Inhibition of the cardiac Na⁺ channel α-subunit Nav1.5 by propofol and dexmedetomidine.

Authors:  Carsten Stoetzer; Svenja Reuter; Thorben Doll; Nilufar Foadi; Florian Wegner; Andreas Leffler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-12-15       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.